Neurotensin inhibition of canine intestinal motility in vivo via α-adrenoceptors
- 1 April 1984
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 62 (4) , 403-411
- https://doi.org/10.1139/y84-064
Abstract
Neurotensin given intraarterially [i.a.] in bolus doses to the canine small intestine inhibited field-stimulated, atropine-sensitive contractile responses in the duodenum (mean effective dose (ED50) = 3.2 .times. 10-11 mol) and in the ileum (mean ED50) = 2.1 .times. 10-11 mol). Norepinephrine (ED50 = 3 .times. 10-9 mol) also inhibited these conractile responses. Phenylephrine (ED50 = 1.3 .times. 10-8 mol) was 1/4 as potent as norepinephrine and clonidine (ED50 = 8 .times. 10-10 mol) was at least as potent as norepinephrine, while isoproterenol (up to 8 .times. 108 mol) failed to show any inhibitory effects. Phentolamine (2 mg/kg) increased significantly the ED50 of neurotensin and norepinephrine. Prazosin (2 mg/kg) increased significantly the ED50 of norepinephrine in the duodenum but had no effect on the ED50 of neurotensin. Yohimbine (2 mg/kg) increased the ED50 values of neurotensin and adrenergic agonists. Both neurotensin and norepinephrine in doses causing maximal inhibition of field-stimulated responses decreased (by 40 to 60%) contracile responses to 9 .times. 10-10 mol (approximately the i.a. ED50 dose) of acetylcholine. Reserpine pretreatment markedly diminished the inhibition of spontaneous or field-stimulated phasic contractions by distension or field stimulation of a distal site. Reserpine also diminished the ED50 for neurotensin from 1 .times. 10-11 to 2 .times. 10-11 mol (p DAR 0.02), but did not abolish neurotensin''s inhibitory effect. Tetrodotoxin (10-15 .mu.g, i.a.) increased the dose of neurotensin required to inhibit spontaneous activity in the ileum but apparently inhibited contractile activity of canine intestine by acting on neural receptors to release norepinephrine. Norepinephrine activated primarily .alpha.2-adrenoceptors and ultimately inhibited acetylcholine release. Neurotensin also inhibited contractions by activating a second, less sensitive receptor on smooth muscle.This publication has 10 references indexed in Scilit:
- Cholinergic control mechanisms for immunoreactive motilin release and motility in the canine duodenumCanadian Journal of Physiology and Pharmacology, 1983
- Sites and mechanisms of action of neuropeptides on canine gastric motility differ andLife Sciences, 1983
- Mechanisms of action of neurotensin on motility of canine gastric corpus in vitroCanadian Journal of Physiology and Pharmacology, 1983
- The effects of substance P and met-enkephalin in dog ileumCanadian Journal of Physiology and Pharmacology, 1982
- Radioimmunoassay of neurotensin and the distribution and concentration of gut neurotensin in rat and dog.The Tohoku Journal of Experimental Medicine, 1980
- The mechanism of the clonidine-induced reduction in peripheral parasympathetic submaxillary salivationEuropean Journal of Pharmacology, 1979
- Postoperative intestinal motility in dogs and sheepDigestive Diseases and Sciences, 1978
- Inhibition of Gastric and Intestinal Motor Activity in Dogs by (Gln4) NeurotensinActa Physiologica Scandinavica, 1977
- Localization of Adrenergic Receptors in Guinea Pig Ileum and Rabbit Jejunum to Cholinergic Neurons and to Smooth Muscle CellsActa Physiologica Scandinavica, 1977
- Evidence for immunoreactive neurotensin in dog intestinal mucosaLife Sciences, 1976